Literature DB >> 31338699

Response: Leflunomide: potential treatment and cause of alopecia areata.

Greg Koller1, Jill Hall2, Carrie Ye2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31338699     DOI： 10.1007/s10067-019-04689-w

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Alopecia areata during etanercept therapy.

Authors:  Ying Pan; Narsing A Rao
Journal:  Ocul Immunol Inflamm       Date:  2009 Mar-Apr       Impact factor: 3.070

2.  TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.

Authors:  Sean E Mazloom; Di Yan; Jeffery Z Hu; Jason Ya; M Elaine Husni; Christine B Warren; Anthony P Fernandez
Journal:  J Am Acad Dermatol       Date:  2018-12-18       Impact factor: 11.527

Review 3.  Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases.

Authors:  Martin Havmose; Simon Francis Thomsen
Journal:  Int J Dermatol       Date:  2017-07-24       Impact factor: 2.736

4.  Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.

Authors:  Lluís Puig
Journal:  Curr Probl Dermatol       Date:  2017-11-07

5.  Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

Authors:  Marie Tauber; Sébastien Buche; Pascal Reygagne; Jean-Marie Berthelot; François Aubin; Pierre-Dominique Ghislain; Jean-David Cohen; Pascal Coquerelle; Elisa Goujon; Denis Jullien; Hedia Brixi; Géraldine Jeudy; Xavier Guennoc; Antoine Martin; Emilie Brénaut; Emmanuel Hoppé; Antoine Bertolotti; Thomas Bardin; Emmanuel Delaporte; Matthieu Allez; Hervé Bachelez; Julien Seneschal; Manuelle Viguier
Journal:  J Am Acad Dermatol       Date:  2014-06       Impact factor: 11.527

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Reversible alopecia areata: a little known side effect of leflunomide.

Authors:  Greg Koller; Ina Cusnir; Jill Hall; Carrie Ye
Journal:  Clin Rheumatol       Date:  2019-05-01       Impact factor: 2.980

8.  Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.

Authors:  Leona A Doyle; Leonard C Sperling; Shashi Baksh; Jeffrey Lackey; Brian Thomas; Ruth Ann Vleugels; Abrar A Qureshi; Elsa F Velazquez
Journal:  Am J Dermatopathol       Date:  2011-04       Impact factor: 1.533

Review 9.  Paradoxical effects of anti-TNF-α agents in inflammatory diseases.

Authors:  Daniel Wendling; Clément Prati
Journal:  Expert Rev Clin Immunol       Date:  2013-12-10       Impact factor: 4.473

10.  Alopecia areata following adalimumab.

Authors:  Carly Kirshen; Nordau Kanigsberg
Journal:  J Cutan Med Surg       Date:  2009 Jan-Feb       Impact factor: 2.092
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.